Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer

Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer

Monoclonal antibodies are among the most effective tools for detecting tumor-associated antigens. The U.S. Food and Drug Administration (FDA) has approved more than 36 therapeutic antibodies for developing novel alternative therapies that have significant success rates in fighting cancer. However, s...

Full description

Bibliographic Details
Main Authors: Cynthia Rodríguez-Nava, Carlos Ortuño-Pineda, Berenice Illades-Aguiar, Eugenia Flores-Alfaro, Marco Antonio Leyva-Vázquez, Isela Parra-Rojas, Oscar del Moral-Hernández, Amalia Vences-Velázquez, Karen Cortés-Sarabia, Luz del Carmen Alarcón-Romero
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Biomedicines
Subjects:
cancer
monoclonal antibodies
scFv
treatment
mechanism of action
Online Access:https://www.mdpi.com/2227-9059/11/6/1610

Internet

https://www.mdpi.com/2227-9059/11/6/1610

Similar Items